These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 22425248)

  • 21. The Energy Sensor AMPKα1 Is Critical in Rapamycin-Inhibition of mTORC1-S6K-Induced T-cell Memory.
    Ara A; Xu A; Ahmed KA; Leary SC; Islam MF; Wu Z; Chibbar R; Xiang J
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-12 Influence mTOR to Modulate CD8
    Wang H; Li J; Han Q; Yang F; Xiao Y; Xiao M; Xu Y; Su L; Cui N; Liu D
    Int J Med Sci; 2017; 14(10):977-983. PubMed ID: 28924369
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunity.
    Li Q; Rao R; Vazzana J; Goedegebuure P; Odunsi K; Gillanders W; Shrikant PA
    J Immunol; 2012 Apr; 188(7):3080-7. PubMed ID: 22379028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunology: A metabolic switch to memory.
    Prlic M; Bevan MJ
    Nature; 2009 Jul; 460(7251):41-2. PubMed ID: 19571872
    [No Abstract]   [Full Text] [Related]  

  • 25. Eomesodermin driven IL-10 production in effector CD8
    Reiser J; Sadashivaiah K; Furusawa A; Banerjee A; Singh N
    Cell Immunol; 2019 Jan; 335():93-102. PubMed ID: 30528350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin-mediated FOXO1 inactivation reduces the anticancer efficacy of rapamycin.
    Abdelnour-Berchtold E; Cerantola Y; Roulin D; Dormond-Meuwly A; Demartines N; Dormond O
    Anticancer Res; 2010 Mar; 30(3):799-804. PubMed ID: 20392999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A color-coded reporter model to study the effect of immunosuppressants on CD8+ T-cell memory in antitumor and alloimmune responses.
    Rovira J; Sabet-Baktach M; Eggenhofer E; Lantow M; Koehl GE; Schlitt HJ; Campistol JM; Geissler EK; Kroemer A
    Transplantation; 2013 Jan; 95(1):54-62. PubMed ID: 23222894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tsc1 promotes the differentiation of memory CD8+ T cells via orchestrating the transcriptional and metabolic programs.
    Shrestha S; Yang K; Wei J; Karmaus PW; Neale G; Chi H
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14858-63. PubMed ID: 25271321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation.
    Takemoto N; Intlekofer AM; Northrup JT; Wherry EJ; Reiner SL
    J Immunol; 2006 Dec; 177(11):7515-9. PubMed ID: 17114419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche.
    Banerjee A; Gordon SM; Intlekofer AM; Paley MA; Mooney EC; Lindsten T; Wherry EJ; Reiner SL
    J Immunol; 2010 Nov; 185(9):4988-92. PubMed ID: 20935204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycomb Repressive Complex 2-Mediated Chromatin Repression Guides Effector CD8
    Gray SM; Amezquita RA; Guan T; Kleinstein SH; Kaech SM
    Immunity; 2017 Apr; 46(4):596-608. PubMed ID: 28410989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.
    Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM
    J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased numbers of preexisting memory CD8 T cells and decreased T-bet expression can restrain terminal differentiation of secondary effector and memory CD8 T cells.
    Joshi NS; Cui W; Dominguez CX; Chen JH; Hand TW; Kaech SM
    J Immunol; 2011 Oct; 187(8):4068-76. PubMed ID: 21930973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous activity of Foxo1 is required to prevent anergy and maintain the memory state of CD8
    Delpoux A; Michelini RH; Verma S; Lai CY; Omilusik KD; Utzschneider DT; Redwood AJ; Goldrath AW; Benedict CA; Hedrick SM
    J Exp Med; 2018 Feb; 215(2):575-594. PubMed ID: 29282254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Id2-mediated inhibition of E2A represses memory CD8+ T cell differentiation.
    Masson F; Minnich M; Olshansky M; Bilic I; Mount AM; Kallies A; Speed TP; Busslinger M; Nutt SL; Belz GT
    J Immunol; 2013 May; 190(9):4585-94. PubMed ID: 23536629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection.
    Omilusik KD; Best JA; Yu B; Goossens S; Weidemann A; Nguyen JV; Seuntjens E; Stryjewska A; Zweier C; Roychoudhuri R; Gattinoni L; Bird LM; Higashi Y; Kondoh H; Huylebroeck D; Haigh J; Goldrath AW
    J Exp Med; 2015 Nov; 212(12):2027-39. PubMed ID: 26503445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-150-Mediated Foxo1 Regulation Programs CD8
    Ban YH; Oh SC; Seo SH; Kim SM; Choi IP; Greenberg PD; Chang J; Kim TD; Ha SJ
    Cell Rep; 2017 Sep; 20(11):2598-2611. PubMed ID: 28903041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1.
    Brown J; Wang H; Suttles J; Graves DT; Martin M
    J Biol Chem; 2011 Dec; 286(52):44295-305. PubMed ID: 22045807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical role for all-trans retinoic acid for optimal effector and effector memory CD8 T cell differentiation.
    Allie SR; Zhang W; Tsai CY; Noelle RJ; Usherwood EJ
    J Immunol; 2013 Mar; 190(5):2178-87. PubMed ID: 23338237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foxo transcription factors control regulatory T cell development and function.
    Kerdiles YM; Stone EL; Beisner DR; McGargill MA; Ch'en IL; Stockmann C; Katayama CD; Hedrick SM
    Immunity; 2010 Dec; 33(6):890-904. PubMed ID: 21167754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.